Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shilpa Medicare Limited ( (IN:SHILPAMED) ) has shared an announcement.
Shilpa Medicare Limited has announced the closure of its trading window for designated persons, their immediate relatives, and other connected persons in line with SEBI’s Prohibition of Insider Trading Regulations, 2015. The window will be closed from April 1, 2026 until 48 hours after the board approves the audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026, underscoring the company’s adherence to governance norms and signaling the upcoming earnings announcement to investors.
During this blackout period, all designated insiders are barred from trading in the company’s securities, aiming to prevent misuse of unpublished price-sensitive information. The company will separately inform the market of the board meeting date for considering the audited results, a step that helps maintain orderly trading and provides clarity to shareholders and market participants about the timing of key financial disclosures.
More about Shilpa Medicare Limited
Shilpa Medicare Limited is an India-based pharmaceutical company engaged in manufacturing and supplying healthcare products. Listed on both BSE and NSE, the company operates from its corporate office in Raichur, Karnataka, and focuses on regulated market compliance and transparent disclosure to capital markets.
Average Trading Volume: 24,644
Technical Sentiment Signal: Buy
Current Market Cap: 61.07B INR
Learn more about SHILPAMED stock on TipRanks’ Stock Analysis page.